Skip to main content

Volume 15 - Issue 5 - May, 2003

Commentary
08/01/2008
Alborz Hassankhani, MD, PhD; Brian Funaki, MD; William F. Penny, MD
To the Editor: Recently, I have treated a number of patients with functioning dialysis fistulae or synthetic arteriovenous grafts referred for arm swelling developing after pacemaker insertion (Figure A). Invariably, a stenosis or occlusion...
To the Editor: Recently, I have treated a number of patients with functioning dialysis fistulae or synthetic arteriovenous grafts referred for arm swelling developing after pacemaker insertion (Figure A). Invariably, a stenosis or occlusion...
To the Editor: Recently, I have...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Camille Brasselet, MD; Sophie Parotin, MS; Jean-Francois Fuzellier, MD
The pharmacological and mechanical coronary angioplasty environment extensively enhances the immediate outcome so much that acute procedural complications seem to belong to the past. Other than restenosis, the management of which is now well...
The pharmacological and mechanical coronary angioplasty environment extensively enhances the immediate outcome so much that acute procedural complications seem to belong to the past. Other than restenosis, the management of which is now well...
The pharmacological and...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
08/01/2008
Todd J. Cohen, MD, FACC, FHRS
Recently, the Companion Trial was terminated via the Safety and Monitoring Board for that trial. This was a breakthrough trial in which patients with moderate to severe congestive heart failure (New York Heart Association class III and IV),...
Recently, the Companion Trial was terminated via the Safety and Monitoring Board for that trial. This was a breakthrough trial in which patients with moderate to severe congestive heart failure (New York Heart Association class III and IV),...
Recently, the Companion Trial...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
08/01/2008
Angelo A. de Paola, MD; Luiz R. Leite, MD; Elerson Arfelli, MD
Radiofrequency catheter ablation (RFCA) has become the most effective and safe method for treating Wolff-Parkinson-White (WPW) syndrome in children and adolescents. Accessory pathways (APs) located in the postero-septal region account for up...
Radiofrequency catheter ablation (RFCA) has become the most effective and safe method for treating Wolff-Parkinson-White (WPW) syndrome in children and adolescents. Accessory pathways (APs) located in the postero-septal region account for up...
Radiofrequency catheter ablation...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology, which coincides with the 52nd Annual Scientific Sessions of the American College of Cardiology, includes original research articles, case reports, editorials, articles from the...
Dear Readers, This issue of the Journal of Invasive Cardiology, which coincides with the 52nd Annual Scientific Sessions of the American College of Cardiology, includes original research articles, case reports, editorials, articles from the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Andrew G.C. Sutton, MA, MD, MRCP; P. Finn; P.G. Campbell; D.G.A. Price; J.A. Hall; M.J. Stewart; A. Davies; N.J. Linker; Alun A. Harcombe, MD, MRCP; Mark A. de Belder, MA, MD, FRCP
The choice of contrast agent used in diagnostic cardiac catheterization might be considered relatively unimportant compared to decisions on arterial access, choice of catheters and potential technical pitfalls. However, the choice of contrast...
The choice of contrast agent used in diagnostic cardiac catheterization might be considered relatively unimportant compared to decisions on arterial access, choice of catheters and potential technical pitfalls. However, the choice of contrast...
The choice of contrast agent...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Fayaz Shawl, MD
Some Patients Can’t Be Revascularized with PCI or CABG Despite the advances that have occurred in coronary revascularization, there is a growing population of patients who are not candidates for either coronary artery bypass grafting (CABG)...
Some Patients Can’t Be Revascularized with PCI or CABG Despite the advances that have occurred in coronary revascularization, there is a growing population of patients who are not candidates for either coronary artery bypass grafting (CABG)...
Some Patients Can’t Be...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
C.H. Wong, MD; C.W. Lam, MD; Steven Siu-Lung Li, MD
Renal artery stenosis may occur in combination with hypertension and renal function impairment. Renal artery revascularization with angioplasty may facilitate hypertension control and preserve renal function.1,2 However, distal embolization...
Renal artery stenosis may occur in combination with hypertension and renal function impairment. Renal artery revascularization with angioplasty may facilitate hypertension control and preserve renal function.1,2 However, distal embolization...
Renal artery stenosis may occur...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Randy Wolcoot, MD; Scot Schultz, MD; Paula D. Ambra, PA-C; Silvio Travalia, MD
Thrombolytic therapy and surgery are 2 approaches to the treatment of mechanical valve thrombosis (MVT). Because surgery is an invasive and very costly procedure, noninvasive thrombolytic therapy may be a practical and effective treatment...
Thrombolytic therapy and surgery are 2 approaches to the treatment of mechanical valve thrombosis (MVT). Because surgery is an invasive and very costly procedure, noninvasive thrombolytic therapy may be a practical and effective treatment...
Thrombolytic therapy and surgery...
08/01/2008
Journal of Invasive Cardiology
Editorial
08/01/2008
Gerald Dorros, MD, DSc, FACC, ScD
Balloons, stents and embolic protection devices, as treatment for extracranial obliterative disease, have created in recent decades a predicament not dissimilar to the percutaneous treatment of coronary angioplasty and mitral valvuloplasty....
Balloons, stents and embolic protection devices, as treatment for extracranial obliterative disease, have created in recent decades a predicament not dissimilar to the percutaneous treatment of coronary angioplasty and mitral valvuloplasty....
Balloons, stents and embolic...
08/01/2008
Journal of Invasive Cardiology
Editorial
08/01/2008
Gerald Dorros, MD, DSc, FACC, ScD
Conclusions. As this nascent period of endovascular carotid procedures draws to an end, what is clear, crystal clear to me, is that a significant conundrum exists. The Gordian knot to be unraveled is not whether stent-supported carotid...
Conclusions. As this nascent period of endovascular carotid procedures draws to an end, what is clear, crystal clear to me, is that a significant conundrum exists. The Gordian knot to be unraveled is not whether stent-supported carotid...
Conclusions. As this nascent...
08/01/2008
Journal of Invasive Cardiology
Practice Management and Economics
08/01/2008
Ron Schmidt
Just over three years ago, the President and CEO of Parma Community General Hospital (PCGH) and his administrative team decided to expand the cardiovascular service line to include open-heart surgery (OHS) and interventional cardiac...
Just over three years ago, the President and CEO of Parma Community General Hospital (PCGH) and his administrative team decided to expand the cardiovascular service line to include open-heart surgery (OHS) and interventional cardiac...
Just over three years ago, the...
08/01/2008
Journal of Invasive Cardiology
Practice Management and Economics
08/01/2008
Ronald N. Riner, MD, FACC
The article on the One Stop Post Op Unit in this issue points to a rather innovative way of taking care of postoperative patients. Peter Drucker, one of the more renowned management thinkers of our time, constantly extols the fact that...
The article on the One Stop Post Op Unit in this issue points to a rather innovative way of taking care of postoperative patients. Peter Drucker, one of the more renowned management thinkers of our time, constantly extols the fact that...
The article on the One Stop Post...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
David J. D'Agate, DO; Spyros Kokolis, MD; Nehad Soloman, MD; Elise Belilos, MD; Steven Carsons, MD; George D. Dangas, MD, PhD; Julia Andrieni, MD; Thomas Argyros, MD; Lynne A. Glasser, MD
Advances in medical therapy and a better understanding of systemic lupus erythematosus (SLE) have contributed to a dramatic improvement in the long-term survival of patients. However, despite the overall long-term improvement, coronary artery...
Advances in medical therapy and a better understanding of systemic lupus erythematosus (SLE) have contributed to a dramatic improvement in the long-term survival of patients. However, despite the overall long-term improvement, coronary artery...
Advances in medical therapy and...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Jorgo Kostov, MD; Antonio Colombo, MD; Goran Stankovic, MD
The incidence of chronic total occlusions (CTO) is between 20–40% in patients with angiographically documented coronary artery disease.1 Percutaneous coronary intervention (PCI) for chronic total occlusion is associated with a significantly...
The incidence of chronic total occlusions (CTO) is between 20–40% in patients with angiographically documented coronary artery disease.1 Percutaneous coronary intervention (PCI) for chronic total occlusion is associated with a significantly...
The incidence of chronic total...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Heidi N. Bonneau, RN, MS; Shinjo Sonoda, MD; Toru Kataoka, MD; Yasuhiro Honda, MD; Peter J. Fitzgerald, MD, PhD; Gary S. Mintz, MD; Paul G. Yock, MD; Krishnankutty Sudhir, MD, PhD
Reduction of restenosis remains an important goal of percutaneous coronary interventions. Although coronary stents reduce the rate of primary restenosis compared with balloon angioplasty,1–3 20–30% of treated vessels still develop recurrent...
Reduction of restenosis remains an important goal of percutaneous coronary interventions. Although coronary stents reduce the rate of primary restenosis compared with balloon angioplasty,1–3 20–30% of treated vessels still develop recurrent...
Reduction of restenosis remains...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ray J. Wainwright, BSc, MD; Thuraia Nageh, MD, MRCP; Martyn R. Thomas, MD, FRCP; Roy A. Sherwood, DPhil; Beverley M. Harris, MSc; David E. Jewitt, BSc, MD
There has been a dramatic increase in the use of intracoronary stents as the primary percutaneous treatment strategy for coronary lesions. This shift was supported by evidence demonstrating improved acute and long-term outcomes with stenting...
There has been a dramatic increase in the use of intracoronary stents as the primary percutaneous treatment strategy for coronary lesions. This shift was supported by evidence demonstrating improved acute and long-term outcomes with stenting...
There has been a dramatic...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Michael R. Mooney, MD; Arturo G. Touchard, MD; Wesley D. Pedersen, MD; Robert S. Schwartz, MD
Conventional stenting techniques initially incorporated routine target lesion predilatation with a balloon catheter to permit easy, uncomplicated stent passage prior to stent deployment. With extensive experience in stenting, cardiac...
Conventional stenting techniques initially incorporated routine target lesion predilatation with a balloon catheter to permit easy, uncomplicated stent passage prior to stent deployment. With extensive experience in stenting, cardiac...
Conventional stenting techniques...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Salvatore L. Battaglia, MD, BS; Lynn G. Tarkington, RN; Edmund R. Becker, PhD; Steven D. Culler, PhD; Michael J. Mack, MD, FACC; Aaron D. Kugelmass, MD; David J. Cohen, MD, MPH, MSc; Frank Houser, MD; April W. Simon, RN, MSN
Rapid advancements in percutaneous coronary interventional (PCI) techniques have changed the manner in which we treat coronary artery disease.1 Clinical trials have demonstrated the efficacy of coronary stents in preventing abrupt vessel...
Rapid advancements in percutaneous coronary interventional (PCI) techniques have changed the manner in which we treat coronary artery disease.1 Clinical trials have demonstrated the efficacy of coronary stents in preventing abrupt vessel...
Rapid advancements in...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Eric J. Topol, MD; Danielle M. Brennan, MS; Mark G. Midei, MD; Dean J. Kereiakes, MD, FACC, MSCAI; Dean Nukta, MD; Donel Murphy, RN; Sorin J. Brener, MD; David J. Moliterno, MD; David G. Rizik, MD, FACC, FSCAI
As compared with balloon angioplasty alone, coronary stent implantation has resulted in improved clinical outcomes and lower clinical restenosis rates.1–3 The latter is not due to less neointimal proliferation, but rather to a larger initial...
As compared with balloon angioplasty alone, coronary stent implantation has resulted in improved clinical outcomes and lower clinical restenosis rates.1–3 The latter is not due to less neointimal proliferation, but rather to a larger initial...
As compared with balloon...
08/01/2008
Journal of Invasive Cardiology